Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cessation of Migraine Headaches With Patent Foramen Ovale-Directed Therapy (COMFORT - PFO): An Investigator-Initiated Study

NCT07629635 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT07629635
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07629635 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cessation of Migraine Headaches With Patent Foramen Ovale-Directed Therapy (COMFORT - PFO): An Investigator-Initiated Study
Lead sponsor
Columbia University
Phase
Phase 3
Overall status
Recruiting
Start date
October 15, 2026
Completion date
March 31, 2028
Enrollment
32 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

migraine disease, patent foramen ovale